354 related articles for article (PubMed ID: 7622822)
1. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.
Montgomery SA; Kasper S
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():33-40. PubMed ID: 7622822
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.
Montgomery SA; Henry J; McDonald G; Dinan T; Lader M; Hindmarch I; Clare A; Nutt D
Int Clin Psychopharmacol; 1994; 9(1):47-53. PubMed ID: 8195583
[TBL] [Abstract][Full Text] [Related]
3. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis.
Arroll B; Macgillivray S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
Ann Fam Med; 2005; 3(5):449-56. PubMed ID: 16189062
[TBL] [Abstract][Full Text] [Related]
6. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
Anderson IM
Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
[TBL] [Abstract][Full Text] [Related]
7. Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis.
Undurraga J; Baldessarini RJ
J Psychopharmacol; 2017 Sep; 31(9):1184-1189. PubMed ID: 28633600
[TBL] [Abstract][Full Text] [Related]
8. A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis.
Wilson K; Mottram P
Int J Geriatr Psychiatry; 2004 Aug; 19(8):754-62. PubMed ID: 15290699
[TBL] [Abstract][Full Text] [Related]
9. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2000; (4):CD002791. PubMed ID: 11034764
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Pollok J; van Agteren JE; Carson-Chahhoud KV
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis.
Liu J; Dong J; Wang L; Su Y; Yan P; Sun S
PLoS One; 2013; 8(10):e76651. PubMed ID: 24098546
[TBL] [Abstract][Full Text] [Related]
13. Antidepressants for depressed elderly.
Mottram P; Wilson K; Strobl J
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003491. PubMed ID: 16437456
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
[TBL] [Abstract][Full Text] [Related]
15. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.
Anderson IM; Tomenson BM
BMJ; 1995 Jun; 310(6992):1433-8. PubMed ID: 7613276
[TBL] [Abstract][Full Text] [Related]
16. Does the use of SSRIs reduce medical care utilization and expenditures?
Chung S
J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity.
Hotopf M; Hardy R; Lewis G
Br J Psychiatry; 1997 Feb; 170():120-7. PubMed ID: 9093499
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine versus other types of pharmacotherapy for depression.
Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C
Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
